Business Context and Reporting Period
Puma Biotechnology, Inc. filed a Current Report on Form 8-K on November 6, 2017, reporting events occurring on October 31, 2017. The filing details the entry into a material definitive agreement involving a new credit facility.
Key Financial Metrics and Debt Structure
The Company entered into a loan and security agreement with Silicon Valley Bank (SVB) and Oxford Finance LLC for an aggregate term loan amount of $100 million.
- Term Loan A: $50 million funded immediately on the Effective Date.
- Term Loan B: $50 million available at the Company's option between March 31, 2018, and June 30, 2018, contingent on achieving a specified minimum revenue milestone and no event of default.
- Interest Rate: The greater of 7.75% or the prime rate plus 3.5%.
- Repayment Terms: Monthly interest-only payments until December 1, 2019, followed by equal monthly principal and interest payments. Full maturity is October 31, 2022.
- Final Payment: A payment equal to 7.5% of the original principal amount of funded Term Loans is due upon repayment.
- Upfront Fees: $1.5 million total ($750,000 facility fee and $750,000 arrangement fee).
- Collateral: Substantially all personal property (excluding intellectual property) and 65% of the capital stock of subsidiary Puma Biotechnology Ltd.
Material Changes and Covenants
This filing represents a significant change in the Company's capital structure, introducing substantial new debt obligations and restrictive covenants.
- Revenue Covenants: The Company must achieve product revenue targets measured on a trailing 3-month basis:
- 2017: Greater than or equal to 70% of board-approved projections.
- 2018 and 2019: Greater than or equal to 50% of board-approved projections.
- Negative Covenants: Restrictions on incurring additional indebtedness, mergers, acquisitions, paying dividends, making investments, creating liens, and changes in control.
- Prepayment Penalties: 2.0% fee if prepaid within the first anniversary; 1.0% fee if prepaid between the first and second anniversary.
Outlook, Risks, and Contingencies
The credit facility includes events of default that could trigger a 5.0% penalty interest rate and allow lenders to exercise remedies, including foreclosure on collateral and cash. Events of default include failure to pay principal or interest, breach of covenants, insolvency, material adverse change, or judgments exceeding $500,000. The filing does not provide specific revenue guidance numbers, only the percentage thresholds required to maintain the facility.
Investor Verification Checklist
- Verify the Company's current cash position and ability to service the $50 million immediate debt obligation.
- Confirm the specific board-approved revenue projections for 2017, 2018, and 2019 to assess the feasibility of the 70% and 50% revenue covenants.
- Review the impact of the 7.5% final payment obligation on the total cost of capital.
- Assess the restrictions on future financing and strategic flexibility imposed by the negative covenants.
- Monitor the Company's ability to meet the revenue milestone required to draw the remaining $50 million Term Loan B.